What's new

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Feb 12, 2025 - 10:30
 0
Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Pemetrexed Fresenius K...

Next Article

Regulating the Magnetic Domain of Nickle for Enhanced CO2 Electrochemical Reduct...

Related Posts

Agenda - ACT EU workshop on ICH E6 (R3)

Feb 18, 2025  0

EMEA-003468-PIP01-23

EMEA-003468-PIP01-23

Feb 17, 2025  0

EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2025, 13:30 (CET) to 14 March 2025, 12:30 (CET)

EMA Veterinary Innovation Day, Online, European Medicin...

Feb 13, 2025  0